Oliver Luxxe Assets’s Novartis NVS Stock Holding History

Oliver Luxxe Assets’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,887	Closed	-$823K	–	92
2015 Q4	$823K	Buy	+11,887	New	+$944K	0.74%	48

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Oliver Luxxe Assets's NVS Position: Q1 2016 in Review

Oliver Luxxe Assets sold out of Novartis (NVS) in Q1 2016, closing a stake of 11,887 shares — an estimated $823K sold.

Oliver Luxxe Assets first reported a position in NVS in Q4 2015 and held it in 1 quarter. The position peaked at $823K in Q4 2015. 875 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

Oliver Luxxe Assets reported no remaining Novartis position as of Q1 2016 after selling out during the quarter.
Oliver Luxxe Assets sold 11,887 Novartis shares in Q1 2016, an estimated $823K.
Oliver Luxxe Assets first reported a position in Novartis in Q4 2015 and held it in 1 quarter.
Oliver Luxxe Assets's Novartis position peaked at $823K in Q4 2015.
875 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on Oliver Luxxe Assets's 13F filing for Q1 2016, filed 19 Apr 2016.